EquityFlowCompanies › Phagos

Phagos

Biotech · FR

Terapie fagiche personalizzate guidate da AI contro la resistenza agli antibiotici, a partire dalla salute animale.

Funding history

DateRoundAmount
Oct 2025Series A
Phagos raised a €25 million Series A co-led by CapAgro, Hoxton Ventures, CapHorn and Demeter.
$29M

Investors

Acurio VenturesCapHornCapagroCitizen CapitalDemeterEntrepreneur FirstFounders CapitalHoxton VenturesStation F

Similar companies in Biotech

Explore funding flow on EquityFlow →